HOME >> BIOLOGY >> NEWS
Gene thwarts some pathogens, gives access to others, could save crops

activity that is characteristic of proteins that act as enzymes. This finding led researchers to believe that these molecules give the early signals needed to set off a relay of biochemical events allowing the plant to fight off the pathogen, Mengiste said.

"Basically the BIK1 protein does this by regulating a plant defense hormone called salicylic acid," he said. "The amount of salicylic acid determines the type and level of a plant's response to the pathogen. This is very important in terms of disease resistance.

"In this paper, we speculate that there is an optimum level of salicylic acid that is required for pathogen defense. When that level is exceeded, in some cases it may promote susceptibility to other pathogens by interfering with other defense strategies of the plants."

The research team first looked at normal plants and then at the BIK1 mutant when they began to study the effect of different hormones on plant growth and pathogen defense, Mengiste said. The scientists were surprised to find that the mutants had reduced primary root growth but increased numbers of root hairs. Along with their other findings, this revelation is leading the scientists to future research.

"It looks like this gene actually links pathogen response to plant growth and development," Mengiste said. "But how a single protein regulates these two processes that are singularly independent, we don't know. That is the main purpose of our future studies.

"We need to figure out the details of how it regulates root growth and the length and amount of root hair. This may have implications in terms of nutrient absorption or total plant biomass."

The answers eventually could lead to increased crop yield and decreased produce loss due to Botrytis and other similar pathogens, he said.

Currently, the gray mold disease caused by Botrytis destroys about 10 percent of the grape crop annually and about 25 percent to 30 percent of tomato and str
'"/>

Contact: Susan A. Steeves
ssteeves@purdue.edu
765-496-7481
Purdue University
3-Feb-2006


Page: 1 2 3

Related biology news :

1. Disease damages wheat roots, thwarts water uptake
2. Infectious agent thwarts typical defense mechanisms; Sheds light on immune system function
3. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
4. Brain blood flow gives clues to treating depression
5. Immune system escape hatch gives cancer cells traction
6. Investigating Life in Extreme Environments report gives hints on facts of life
7. 5.9 million award gives UK aging research a new lease on life
8. Neuronal activity gives clues to working memory
9. Study of damaged gene gives insight into causes of mental illness
10. Human pubic lice acquired from gorillas gives evolutionary clues
11. DNA gives new perspectives to understand the mysteries of nature

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gene thwarts some pathogens gives access others could save crops

(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "Global Facial Recognition ... http://photos.prnewswire.com/prnh/20130307/600769 ... identification of individuals. Facial recognition system measures the ... nose, jaw edges, mouth, and the distance between ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has ... in India 2015-2019" report to their offering. ... this market is the adoption of multimodal biometric ... characteristic of an individual for verification and identification ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/17/2014)... 2014 Ipsen Biopharmaceuticals, Inc., an ... IPSEY), today announced that Somatuline® Depot® ... was approved by the U.S. Food and Drug ... tumors (GEP-NETs) in adult patients with unresectable, well ... to improve progression-free survival (PFS). , “The approval ...
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... announced the next step in its expanded strategy to ... with the naming of current Chief Operating Officer, ... while current Chairman of the Board and CEO ... These changes are effective January 1, 2015. ...
(Date:12/17/2014)... Calif. , Dec. 17, 2014 ... a Phase 2 study evaluating the investigational oral ... of patients with severe, chronic itch who are ... of care, including topical steroids and antihistamines. ... change in Visual Analog Scale (VAS) itch score ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
Cached News: